Follow
Eric Tran
Eric Tran
Earle A. Chiles Research Institute, Providence Cancer Center
Verified email at providence.org
Title
Cited by
Cited by
Year
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
E Tran, S Turcotte, A Gros, PF Robbins, YC Lu, ME Dudley, ...
Science 344 (6184), 641-645, 2014
24482014
T-cell transfer therapy targeting mutant KRAS in cancer
E Tran, PF Robbins, YC Lu, TD Prickett, JJ Gartner, L Jia, A Pasetto, ...
New England Journal of Medicine 375 (23), 2255-2262, 2016
12732016
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
A Gros, PF Robbins, X Yao, YF Li, S Turcotte, E Tran, JR Wunderlich, ...
The Journal of clinical investigation 124 (5), 2246-2259, 2014
11022014
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
A Gros, MR Parkhurst, E Tran, A Pasetto, PF Robbins, S Ilyas, TD Prickett, ...
Nature medicine 22 (4), 433-438, 2016
8602016
Identification of essential genes for cancer immunotherapy
SJ Patel, NE Sanjana, RJ Kishton, A Eidizadeh, SK Vodnala, M Cam, ...
Nature 548 (7669), 537-542, 2017
8182017
Immunogenicity of somatic mutations in human gastrointestinal cancers
E Tran, M Ahmadzadeh, YC Lu, A Gros, S Turcotte, PF Robbins, ...
Science 350 (6266), 1387-1390, 2015
7582015
'Final common pathway'of human cancer immunotherapy: targeting random somatic mutations
E Tran, PF Robbins, SA Rosenberg
Nature immunology 18 (3), 255-262, 2017
4432017
Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
E Tran, D Chinnasamy, Z Yu, RA Morgan, CCR Lee, NP Restifo, ...
Journal of Experimental Medicine 210 (6), 1125-1135, 2013
3912013
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics
JG Crompton, M Sukumar, R Roychoudhuri, D Clever, A Gros, RL Eil, ...
Cancer research 75 (2), 296-305, 2015
3542015
Neoantigen T-cell receptor gene therapy in pancreatic cancer
R Leidner, N Sanjuan Silva, H Huang, D Sprott, C Zheng, YP Shih, ...
New England Journal of Medicine 386 (22), 2112-2119, 2022
2742022
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
P Malekzadeh, A Pasetto, PF Robbins, MR Parkhurst, BC Paria, L Jia, ...
The Journal of clinical investigation 129 (3), 2021
2342021
Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers
MR Parkhurst, PF Robbins, E Tran, TD Prickett, JJ Gartner, L Jia, G Ivey, ...
Cancer discovery 9 (8), 1022-1035, 2019
2112019
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer
D Abate-Daga, KH Lagisetty, E Tran, Z Zheng, L Gattinoni, Z Yu, ...
Human gene therapy 25 (12), 1003-1012, 2014
2062014
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
R Yossef, E Tran, DC Deniger, A Gros, A Pasetto, MR Parkhurst, ...
JCI insight 3 (19), 2018
2042018
Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6
LM Draper, MLM Kwong, A Gros, S Stevanović, E Tran, S Kerkar, ...
Clinical Cancer Research 21 (19), 4431-4439, 2015
1862015
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
RE Beard, Z Zheng, KH Lagisetty, WR Burns, E Tran, SM Hewitt, ...
Journal for immunotherapy of cancer 2, 1-11, 2014
1432014
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
A Gros, E Tran, MR Parkhurst, S Ilyas, A Pasetto, EM Groh, PF Robbins, ...
The Journal of clinical investigation 129 (11), 4992-5004, 2019
1352019
Immunologic recognition of a shared p53 mutated neoantigen in a patient with metastatic colorectal cancer
W Lo, M Parkhurst, PF Robbins, E Tran, YC Lu, L Jia, JJ Gartner, ...
Cancer immunology research 7 (4), 534-543, 2019
1282019
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
R Duhen, C Ballesteros-Merino, AK Frye, E Tran, V Rajamanickam, ...
Nature Communications 12 (1), 1047, 2021
1212021
Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy
S Turcotte, A Gros, K Hogan, E Tran, CS Hinrichs, JR Wunderlich, ...
The Journal of Immunology 191 (5), 2217-2225, 2013
1212013
The system can't perform the operation now. Try again later.
Articles 1–20